Riskpilot← Back to searchSign inGet full accessGladent AB
ABActiveOrg 5590083878Baggebytorget 4Dental practice care activities · NACE 8623Est. 201510-19 employees
Revenue 2025
SEK 9,8M
+3% vs 2024
EBITDA margin
7.5%
+56% vs 2024
Equity ratio
75.2%
Financial strength
Net profit 2025
SEK 1,9M
+749% vs 2024
| Revenue | SEK 9,8M | +3% |
| EBITDA | SEK 731K | +56% |
| Net profit | SEK 1,9M | +749% |
| Total assets | SEK 7,7M | +5% |
| Equity | SEK 5,8M | +14% |
| Employees | — | — |
Legal name
Gladent AB
Org number
5590083878
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
24 mars 2015
Share capital
SEK 50 000
Employees
10-19
VAT registered
No
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Tandvård
Address
Baggebytorget 4
Phone
+4687526450
Email
thibbe@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 538 | 10 381 | 9 816 | 9 467 | 9 789 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 421 | 1 233 | 1 195 | 469 | 731 |
| Depreciation & amort. | −472 | −258 | −193 | −167 | −171 |
| EBIT | −51 | 975 | 1 002 | 302 | 560 |
| Net financials | 793 | 1 788 | 1 937 | 4 | 1 507 |
| Profit before tax | 742 | 2 764 | 2 939 | 307 | 2 067 |
| Tax | −0 | −210 | −218 | −80 | −139 |
| Net profit | 742 | 2 554 | 2 721 | 227 | 1 928 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 162 | 8 373 | 7 660 | 7 351 | 7 730 |
| Equity | 2 881 | 5 435 | 6 156 | 5 083 | 5 811 |
| Long-term debt | 0 | 889 | 0 | 0 | 0 |
| Short-term debt | 1 518 | 1 287 | 742 | 1 507 | 1 157 |
| Total debt | 1 518 | 2 176 | 742 | 1 507 | 1 157 |
EBITDA margin
7.5%
This company
15.8%
Market median
-53% vs market
20212025
Equity ratio
75.2%
This company
38.2%
Market median
+97% vs market
20212025
Return on equity
33.2%
This company
18.4%
Market median
+80% vs market
20212025
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20212025
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gladent AB 
Karlaplanstandläkarna ABBoard members of Gladent AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alf Jörgen Rickard Sivertsson | Audit | 0 companies |
| Staffan Åke Fredrik Thibblin | Deputy Board Member | 0 companies |
| Anna Eva Maria Ermenc | Chairman | 0 companies |
| Mihael Damjan Ermenc | Board of Directors | 0 companies |